The Long Island community — including two popular local restaurants — is rallying around a 1-year-old West Babylon … ...

A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

iNKT cells combine T and NK cell features, offering multimechanistic killing pathways that may overcome antigen escape in AML treatment. CAR-iNKT cells are derived from healthy donors, reducing costs ...

HONG KONG, Sept. 15, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that its proprietary next-generation humanized IgG4 monoclonal antibody targeting CD47, ligufalimab (AK117), has been ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. The heterogeneity of leukemic cells is the ...

AB Science SA (Euronext - FR0010557264 - AB) today announced the approval of the third of four stages of the Phase I/II study (AB18001) with the compound AB8939 in adult patients with ...